key: cord-0872474-vjjf2h1m authors: Toraih, Eman A.; Sedhom, Jessica A.; Dokunmu, Titilope M.; Hussein, Mohammad H.; Ruiz, Emmanuelle M. L.; Muthusamy, Kunnimalaiyaan; Zerfaoui, Mourad; Kandil, Emad title: Hidden in plain sight: The effects of BCG vaccination in the COVID‐19 pandemic date: 2020-12-17 journal: J Med Virol DOI: 10.1002/jmv.26707 sha: 43cc95101f03ffa07e1fe56162fc41ba64bad284 doc_id: 872474 cord_uid: vjjf2h1m To investigate the relationship between Bacille Calmette‐Guérin (BCG) vaccination and SARS‐CoV‐2 by a bioinformatics approach, two datasets for the SARS‐CoV‐2 infection group and BCG‐vaccinated group were downloaded. Differentially Expressed Genes were identified. Gene ontology and pathways were functionally enriched, and networking was constructed in NetworkAnalyst. Lastly, the correlation between post‐BCG vaccination and COVID‐19 transcriptome signatures was established. A total of 161 DEGs (113 upregulated DEGs and 48 downregulated genes) were identified in the SARS‐CoV‐2 group. In the pathway enrichment analysis, a cross‐reference of upregulated Kyoto Encyclopedia of Genes and Genomes pathways in SARS‐CoV‐2 with downregulated counterparts in the BCG‐vaccinated group, resulted in the intersection of 45 common pathways, accounting for 86.5% of SARS‐CoV‐2 upregulated pathways. Of these intersecting pathways, a vast majority were immune and inflammatory pathways with top significance in interleukin‐17, tumor necrosis factor, NOD‐like receptors, and nuclear factor‐κB signaling pathways. Given the inverse relationship of the specific differentially expressed gene pathways highlighted in our results, the BCG‐vaccine may play a protective role against COVID‐19 by mounting a nonspecific immunological response and further investigation of this relationship is warranted. in addition to its unique geographical distribution, some have hypothesized that protection by the Bacille Calmette-Guérin (BCG) vaccination, a vaccine originally developed to protect against tuberculosis (TB) disease, maybe playing a critical role against COVID-19 spread. [14] [15] [16] [17] [18] [19] BCG is a century-old vaccine that is given as an attenuated live strain of Mycobacterium bovis used to confer immunity against some strains of TB. Various studies have indicated that BCG vaccination has a role extending far beyond TB treatment alone, eliciting nonspecific effects (NSEs) within the innate immune system alongside the adaptive immune response. 20 BCG vaccination has been identified for its protective role specifically against respiratory viral infections, including influenza A and respiratory syncytial virus (RSV), 21 and is the standard therapy for certain types of bladder cancer. Although the exact mechanism remains elusive, BCGprotection is thought to be conferred by epigenetic and immunological moderation of the immune response through the release of proinflammatory cytokines (TNF-α, IL-6, and interferon γ [IFN-γ]) and the role of vitamin D. [22] [23] [24] More specifically, one proposed mechanism dictates that during the antimicrobial response (such as in M. tb infection), toll-like receptors (TLRs) upregulate the expression of vitamin D receptor (VDR) on immune cells and pulmonary epithelial cells. VDR then binds to calcitriol, the active form of vitamin D, and together regulates the transcriptional activity of several antimicrobial peptides such as cathelicidin and β-defensin. [25] [26] [27] [28] Additionally, vitamin D itself alters T-cell activation and IFN-γ stimulation, increasing the expression of several proinflammatory cytokines. Overall, the NSEs following BCG vaccination are conferred by epigenetic and transcriptional modulation of the innate immune system, as evidenced by its far-reaching role in several viral infections beyond TB alone. Furthermore, it has been hypothesized that countries with nationalized BCG vaccination policies show decreased morbidity and mortality to COVID-19 when compared to those where no such uniform policy exists (such as the United States or Italy); however, these preliminary data are limited given it is yet to be peer-reviewed and fails to account for several confounding factors such as age, testing rates, 29, 30 and the accuracy of the BGC World Atlas. 31 Nonetheless, given the safety of BCG vaccination and the well- Overall, the far-reaching effects of BCG vaccination testify to its dynamic role: Eliciting NSEs, curbing inflammation in cancer models, and reducing viremia in several distinct pathogens, including RSV, influenza A, yellow fever, and herpes simplex virus. 21, 32 Altogether, this study aims to elucidate the relationship between BCG vaccination and SARS-CoV-2 through bioinformatic analysis of the biological and immunological pathways underlying both. Defining this relationship is the first step to understanding the role BCG vaccination may play in putative immunity against COVID-19. The microarray data analyzed in this study were obtained from the Gene Expression Omnibus (https://www.ncbi.nlm.nih.gov/geo/), ac- To compare the transcriptomic alterations in SARS-CoV-2 viral infection with host immune response following administration of BCG vaccine, the RNA sequencing data (GSE87186) were retrieved from the SRA database (https://www.ncbi.nlm.nih.gov/geo/query/ acc.cgi?acc=GSE87186) in the Biojupies Analysis Notebook (https:// amp.pharm.mssm.edu/biojupies/analyze) and processed by ARCHS4 (all RNA-seq and ChIP-seq sample and signature search) pipeline (https://amp.pharm.mssm.edu/archs4). 33 In this data set, the immunogenicity of a recombinant BCG vaccine in healthy BCG-naïve adults and those with no prior exposure to M. tb was evaluated. We After background correction of raw expression data, mapped multiple probes to the same genes were summarized to gene levels by using the median. Genes were filtered out based on two criteria: If variance percentile rank lower than the threshold (set at 15%) or low relative abundance (average expression signal) below 5%. To ensure similar expression distributions of each sample across the entire experiment, normalization by the log2 transformation method was performed. The quality of the normalized data set was checked with the box plot and density plot, and the Benjamini and Hochberg method was selected for the multiple testing correction. Using the Limma R package available on Bioconductor (http://bioconductor.org/packages/release/bioc/html/ limma.html), differentially expressed genes (DEGs) were identified in the microarray data set. Genes with a false discovery rate (FDR) < 0.05 and log2-fold change (FC) ≥ 1.0 were considered as significantly differentially expressed and subjected to further analysis. For the RNA seq data of the BCG vaccine, gene expression signature was generated by comparing gene expression levels of the postvaccination groups with the control group on Day 0. Altered patterns of gene expression were defined through each experimental time (FC > 1, p < .05). To visually identify the similarities and differences between different cell line samples, principal component analyses (PCA) were plotted to project highdimensional data into lower dimensions using a linear transformation. Gene Ontology (GO) database for functional annotation of genes was used to analyze the DEGs at the functional level in terms of biological processes, molecular function, and cellular component domains. 34 Pathway functional analysis was performed on the Kyoto Encyclopedia of Genes and Genomes (KEGG) database, Wikipathway, and Reactome pathways. 35 The significantly overrepresented GO and pathways of the upregulated and downregulated DEGs were identified by The Search Tool for the Retrieval of Interacting Genes (STRING) database version 11.0 (https://string-db.org/) and validated in Enrichr website (http://amp.pharm.mssm.edu/Enrichr/) 36 with p-value < .05 as the cut-off criterion. The STRING database was used to construct protein interaction pairs of the screened DEGs based on their function and scores. The setting was adjusted with high confidence (combined score) > 0.9 and the existence of experimental evidence. The network was visualized in Network Analyst (https://www.networkanalyst.ca/), a visual analytics platform for comprehensive gene expression profiling with the following threshold; degree distribution of 20 and betweenness at 10. The hub nodes in the PPI network were then identified based on the connectivity degree in the network statistics (number of neighbors). The gene-miRNA interactome was constructed from experimentally validated miRNA-gene interaction data collected from Raw data for the reads are provided in Table S1 . After normalization, the quality was checked in density and box plots ( Figure S1A ,B). Mock-treated and infected samples showed a clear discrimination pattern in PCA ( Figure S1C ). (Table S2) . Among the most significantly downregulated genes, the fol- (Table S2 ). As depicted in Figure 1C were identified ( Figure 1C and Table S2 ). To explore the functions of the DEGs, the 113 upregulated and 48 downregulated genes were subjected to GO and KEGG pathway enrichment analysis. As shown in Figure (Table S3) . KEGG pathway analysis ( Figure (Table S4 ). In contrast, no significant GO terms or pathways were significant for the downregulated genes. As depicted in Figure 2D , upregulated pathways are highly connected with inflammatory cytokines exhibiting significant crosstalk in particular. IL-6 (also known as B-stimulatory factor-2) is involved in the final differentiation of B cells into immunoglobulinsecreting cells and the induction of acute-phase reactants. IL-6 has sequence similarity with granulocyte colony-stimulating factors 2 and 3 (CSF2 and CSF3), which are also highly expressed following SARS-CoV-2 infection. Furthermore, several interleukins (IL17C, IL19, IL36A, and IL36G) were noted to serve as proinflammatory cytokines for the regulation of dendritic cells and T cells, as well as interleukin-2 receptor subunit gamma (IL2RG), which encodes a common gamma chain essential for IL-receptor function. Overexpression of two members of the CC chemokine family was observed: C-C Motif chemokine ligand 2 (CCL2) and C-C motif chemokine ligand 2 (CCL20), whose function was to induce the migration of monocytes and lymphocytes, respectively (www. GeneCards.org). The gene-miRNA interactions network was constructed ( Figure 2E ). It consisted of 77 seeds (significant genes), 1136 nodes, and 1776 edges mapped to the corresponding molecular interaction databases. KEGG pathway enrichment analysis of the network was significant for four pathways; namely, IL-17 signaling pathway (p = 7E−05, Hits = 5/93), TNF signaling pathway (p = .0017, Hits = 4/110), cytokine-cytokine receptor pathway (p = .012, Hits = 5/294), and influenza A (p = .044, Hits = 3/167). After extraction of nodes relevant to these immune-related pathways, the densely connected microRNAs in the cluster module included: miR-26b-5p, miR-26a-5p, miR-124-3p, miR-7-5p, miR-17-5p, miR-335-5p, mirR-24-3p, miR-203a-3p, and miR-122-5p. Upstream regulatory cell signaling layers responsible for the observed pattern in gene expression following SARS-CoV-2 infection is depicted in Figure 2F Table S13 . Although different genes were modified at each time point, the pathways remained constantly downregulated post-BCG vaccination. and bacterial infections. 32, 60 In one such study, mice inoculated with BCG displayed overall increased resistance to encephalomyocarditis, murine hepatitis, type 1 and 2 herpes simplex, foot-and-mouth disease, and A0 and A2 influenza viruses. 61 Intercellular adhesion molecules (ICAM) included in the upregulated DEGs (Table S1) prescribed cod-liver-remedies rich in vitamin D. 73 Since then, vitamin D has been well characterized for its immunomodulatory properties, including the regulation of IFN-γ, a key activator of macrophage response, 74 and promoting the production of regulatory T cells. 75 In addition to its role in M. tb, 76 cathelicidin is a highly conserved protein that has been shown to direct antiviral activity in several respiratory viral infections including respiratory syncytial virus, human rhinovirus (HRV), and influenza A. [77] [78] [79] [80] [81] [82] In vitro, vitamin D has been shown to counteract the M. tb-induced downregulation of cathelicidin by actually recovering cathelicidin levels and promoting Th1 cell differentiation. Following BCG vaccination, vitamin D levels remain elevated, indicating vitamin D is being upregulated long after the initial inoculation. It has been postulated that increased calcitriol recruits dendritic cells from the site of inoculation to the lymph nodes, accounting for the sustained response. 24 This serves as a possible mechanism of protective effects of BCG vaccination in relation to consistently elevated plasma vitamin D concentration present for as long as 9 months as reported by the authors. 24 Vitamin D deficiency has been shown to contribute to the pathogenesis of ARDS. 83 In children, the mutation in the VDR gene single-nucleotide polymorphism reported in children was associated with a viral infection. 82 Given these findings, the transcriptional upregulation of VDR in SARS-CoV-2 may be contributing to the dysregulation of immunological response by upregulating cytokine response, interrupting microbial peptides, and promoting immune invasion in the lungs; therefore, the well-characterized role of VDR in BCG vaccination could serve as a potential biomarker against COVID-19 disease. In addition to VDR, our bioinformatic analysis showed the de- help to mitigate this pathway dysregulation. Although further experimental validation is warranted to verify our discoveries, the results give insights into potential biomarkers and targeted therapy to address the ongoing COVID-19 pandemic. We maintain BCG vaccination may be a safe and cost-effective alternative in incurring partial protection against the COVID-19 pandemic until more targeted measures can be produced and implemented. The authors declare that there are no conflict of interests. The data that support the findings of this study are available from the corresponding author upon reasonable request. Additional Supporting Information may be found online in the supporting information tab for this article. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak Early dynamics of transmission and control of COVID-19: a mathematical modelling study Spatial modeling could not differentiate early SARS-CoV-2 cases from the distribution of humans on the basis of climate in the United States COVID 19: A comparative study of Asian, European, American continent Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus A new coronavirus associated with human respiratory disease in China Structural and functional basis of SARS-CoV-2 entry by using human ACE2 A dynamic immune response shapes COVID-19 progression The cytokine release syndrome (CRS) of severe COVID-19 and interleukin-6 receptor (IL-6R) BCG vaccination may be protective against Covid-19 Is global BCG vaccination coverage relevant to the progression of SARS-CoV-2 pandemic? Connecting BCG vaccination and COVID-19: additional data Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study Differential COVID-19-attributable mortality and BCG vaccine use in countries. medRxiv Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-19 Nonspecific effects of vaccines and the reduction of mortality in children Non-specific effects of BCG vaccine on viral infections Innate and adaptive immune memory: an evolutionary continuum in the host's response to pathogens Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy Vitamin D-mediated induction of innate immunity in gingival epithelial cells Vitamin D metabolism and innate immunity Vitamin D and immune function Crosstalk between vitamin D metabolism, VDR signalling, and innate immunity Exercising caution in correlating COVID-19 incidence and mortality rates with BCG vaccination policies due to variable rates of SARS CoV-2 testing. medRxiv Global patterns in coronavirus diversity Association between BCG policy is significantly confounded by age and is unlikely to alter infection or mortality rates. medRxiv BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity Massive mining of publicly available RNA-seq data from human and mouse Gene Ontology: tool for the unification of biology Kyoto Encyclopedia of Genes and Genomes Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool Innate IL-17-producing cells: the sentinels of the immune system Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection The role of IL-17 and related cytokines in inflammatory autoimmune diseases TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense NF-κB restricts inflammasome activation via elimination of damaged mitochondria NF-κB signaling in inflammation Deficiency of the NOD-Like receptor NLRC5 results in decreased CD8 + T cell function and impaired viral clearance Up-regulation of IL-6 and TNF-α induced by SARS-coronavirus spike protein in murine macrophages via NF-κB pathway Antiviral potential of ERK/ MAPK and PI3K/AKT/mTOR signaling modulation for Middle East Respiratory Syndrome coronavirus infection as identified by temporal kinome analysis Mycobacterium bovis BCG cell wall-specific differentially expressed genes identified by differential display and cDNA subtraction in human macrophages Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma-and CD40L-mediated costimulation Clinical and immunological features of severe and moderate coronavirus disease 2019 MAP kinases in the immune response Mitogen-activated protein kinases in innate immunity MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits Regulatory mechanisms of mitogen-activated kinase signaling The mitogenactivated protein kinase (MAPK) pathway: role in immune evasion by trypanosomatids Role of MAPK/ MNK1 signaling in virus replication Effect of p38 mitogen-activated protein kinase on the replication of encephalomyocarditis virus Baricitinib as potential treatment for 2019-nCoV acute respiratory disease Mycobacterium bovis bacillus Calmette-Gueérin infection promotes SOCS induction and inhibits IFN-γ-stimulated JAK/STAT signaling in J774 macrophages Non-specific immunity of BCG vaccine: a perspective of BCG immunotherapy Increased resistance to virus infections of mice inoculated with BCG (Bacillus Calmette-Guérin) ICAM-1 regulates the survival of influenza virus in lung epithelial cells during the early stages of infection ICAM-1 receptors and cold viruses Circulating intercellular adhesion molecule-1 (ICAM-1) as an early and sensitive marker for virus-induced T cell activation Human parainfluenza virus type 3 upregulates ICAM-1 (CD54) expression in a cytokineindependent manner Antibody to ICAM-1 mediates enhancement of HIV-1 infection of human endothelial cells Mycobacterium tuberculosis-infected human macrophages exhibit enhanced cellular adhesion with increased expression of LFA-1 and ICAM-1 and reduced expression and/or function of complement receptors, FcgammaRII and the mannose receptor Induction of ICAM 1 expression on bladder tumours by BCG immunotherapy Mycobacterium tuberculosis prevents inflammasome activation Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha, 25-dihydroxyvitamin D3 Human cytomegalovirus infection downregulates vitamin-D receptor in mammalian cells Vitamin D signaling, infectious diseases, and regulation of innate immunity A short history of phototherapy, vitamin D and skin disease Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions Vitamin D and its analogs as regulators of immune activation and antigen presentation Cathelicidin is involved in the intracellular killing of mycobacteria in macrophages Cathelicidins display conserved direct antiviral activity towards rhinovirus The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus The role of vitamin D in prevention and treatment of infection Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response Association between vitamin D receptor gene polymorphisms and response to treatment of pulmonary tuberculosis Confirmation of an association between single nucleotide polymorphisms in the VDR gene with respiratory syncytial virus-related disease in South African children Vitamin D deficiency contributes directly to the acute respiratory distress syndrome (ARDS) Hey genes in cardiovascular development microRNA-146a and Hey2 form a mutual negative feedback loop to regulate the inflammatory response in chronic apical periodontitis Krüppel-like transcription factors: a functional family Kruppel-like factor 2 regulates thymocyte and T-cell migration Egr2 and 3 control adaptive immune responses by temporally uncoupling expansion from T cell differentiation Role for EGR2 in the T-cell response to influenza Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin ligases Chandipura virus utilizes the prosurvival function of RelA NF-κB for its propagation p63 is necessary for the activation of human papillomavirus late viral functions upon epithelial differentiation Mycobacterium tuberculosis decreases human macrophage IFN-γ responsiveness through miR-132 and miR-26a microRNAs in circulation are altered in response to influenza A virus infection in humans MiR-26b inhibits virus replication through positively regulating interferon signaling Respiratory syncytial virus infection inhibits TLR4 signaling via up-regulation of miR-26b MiR-23a facilitates the replication of HSV-1 through the suppression of interferon regulatory factor 1 Regulatory role of small nucleolar RNAs in human diseases A mammalian pseudogene lncRNA at the interface of inflammation and anti-inflammatory therapeutics Tuberculosis vaccines in clinical trials